Please complete the CAPTCHA to continue
@comcast.net
✓
2 phones found area 303
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
David Giarracco is listed as CEO | Board Member | Angel Investor at Noninvasix, based in Boulder, Colorado, United States. AeroLeads shows a work email signal at comcast.net, phone signal with area code 303, and a matched LinkedIn profile for David Giarracco.
David Giarracco previously worked as Chief Executive Officer at Noninvasix and Mentor at Venturewell. David Giarracco holds Master Of Arts - Ma, Biomedical Engineering from The Johns Hopkins University School Of Medicine.
This section adds company-level context without repeating David Giarracco's masked contact details.
AeroLeads found 1 current-domain work email signal for David Giarracco. Compare company email patterns before reaching out.
I am a medical device executive with over twenty-five years of leadership experience spanning quality, engineering, and operations including product line, business integrations and new product launches, six-sigma implementations for both operations and business process, and US and global marketing in surgical and monitoring environments.My leadership was crafted in big corporate America as well as within the start-up ecosystem. My experiences span business development (target identification, business case development, diligence), product development (concept through commercialization), into tactical commercial execution bringing innovative solutions to new sites. Market segments span the "admit to discharge" care continuum including the highest acuity in the OR/ICU through terminal chronic care and home care environments.Skills and Capabilities: Fund raisingBoard ManagementM&A including acquisition, commercial integration and divestiture of global businessSales and Marketing leadership across the healthcare continuumNew Business Opportunity Identification, Assessment and Business Case CreationStrategic PlanningGlobal Market DevelopmentProduct LaunchKey Opinion Leader ManagementClinical Claims Strategy and ManagementOperations ManagementSix Sigma & Lean ImplementationsOrganizational Development
Listed skills include Business Integration, Strategic Planning, Product Launch, Six Sigma, and 50 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Galveston, TX, US
Recruited by the board to fulfill the promise of Noninvasix and be the first to non-invasively monitor the severity of sepsis and septic shock, enabling clinicians to diagnose and monitor the response to treatment of tissue hypoxia in real-time. Our patented optoacoustic platform technology is the first solution to non-invasively and continuously measure.
Hadley, MA, US
ASPIRE is an intensive week-long workshop that prepares startups for the investments and partnerships necessary to launch their ventures. Mentors-in-residence works alongside startups to simulate due diligence conversations and integrate feedback into materials in real-time.
Advised start-up companies in developing and executing their capital fundraising, operational and commercial strategies. Clients included TissueForm, Sachi Bioworks, and Nasaclip.
Denver, CO, US
At SeaStar Medical we recognize that critical care clinicians fight every day to save patients from the cytokine storm. This deadly threat has taken too many organs and too many lives. The severity of this threat is our call to action. We leverage our scientific expertise and resources to break past limitations of current therapies and help our heroes in.
The Builder Fund differentiates itself by identifying exceptional investment opportunities that are often overlooked by traditional funding organizations, by advancing the development of those opportunities. Companies selected for a Builder Fund qualify for investment and/or executive support to better position the company to receive follow-on.
Baltimore, Maryland, US
The successful exit of the company that was acquired by a strategic purchaser and a great return to shareholders that believed in the vision.The World's first platform to enable real-time, 3D measurements of spinal alignment intraoperatively in less than 30 seconds and with up to 80% reduction in radiation exposure compared to current X-ray solutions.
Minneapolis, MN, US
Established first global market development organization for Respiratory Compromise and Postoperative Neurocognitive Disorders.Drove multiple years of double-digit unit adoption and revenue growth, through multimedia awareness activities leveraging evidence and the development of novel services.Accelerated clinical evidence generation through.
Built EMS US commercial and market development organization accountable for revenue attainment.Achieved targets in FY14 and exceeded market growth of 14% in FY15, and 22% in FY16. Implemented market development function for $750M global Respiratory Compromise solutions portfolio.Established business case securing a 10 year $50M investment in Capnography to.
Integrated the sales and marketing organizations of a multisite, multinational $346M Israeli acquisition with experience in restructuring the go-to-market organization.
Hired and developed an organization of product management: implemented mid- year reviews, biannual talent reviews, and marketing journal club to drive culture change organization.
Global business lead for the divestiture of Sleep and Liquid Oxygen Therapy franchises: completed three divestitures, led all aspects of contract negotiations covering US, European and Japan while demonstrating influence management over 450 Covidien employees globally.
Vice President of Marketing for the Sleep and Oxygen business.
Lead the market development activities for a $1B respiratory & monitoring solutions medical device business focused on improving global outcomes in ventilation, monitoring and home healthcare. Defined, developed and recruited the initial market development department in the organization.
Lead the global marketing efforts for a $220M world-wide franchise in electrosurgery. Major repsonsibilities included recruiting a global product management organization, identifying new product opportunities, leadership through the new product development stage gate process, and marketing program identification and implementation.
Quick answers generated from the profile data available on this page.
David Giarracco works for Noninvasix.
David Giarracco is listed as CEO | Board Member | Angel Investor at Noninvasix.
AeroLeads has found 1 work email signal at @comcast.net for David Giarracco at Noninvasix.
AeroLeads has found 2 phone signal(s) with area code 303 for David Giarracco at Noninvasix.
David Giarracco is based in Boulder, Colorado, United States while working with Noninvasix.
David Giarracco has worked for Noninvasix, Venturewell, Nasaclip, Caudate Consulting, Llc, and Seastar Medical.
You can use AeroLeads to view verified contact signals for David Giarracco at Noninvasix, including work email, phone, and LinkedIn data when available.
David Giarracco holds Master Of Arts - Ma, Biomedical Engineering from The Johns Hopkins University School Of Medicine.
David Giarracco is listed with skills including Business Integration, Strategic Planning, Product Launch, Six Sigma, Product Management, Operations Management, Medical Devices, and Organizational Development.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts